VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹37 Cr | ₹37 Cr | ₹41 Cr | ₹132 Cr | ₹78 Cr |
What is the latest Cash Flow from Operating Activities ratio of VENUS REMEDIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹37 Cr |
Mar2023 | ₹37 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹132 Cr |
Mar2020 | ₹78 Cr |
How is Cash Flow from Operating Activities of VENUS REMEDIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹37 Cr | 1.80 | |
Mar2023 | ₹37 Cr | -10.89 | |
Mar2022 | ₹41 Cr | -68.82 | |
Mar2021 | ₹132 Cr | 69.88 | |
Mar2020 | ₹78 Cr | - |
Compare Cash Flow from Operating Activities of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹396.9 Cr | -4.3% | 0.4% | -10.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,430.0 Cr | -3% | -8.7% | 4.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,410.0 Cr | -4.7% | -4.5% | 58.5% | Stock Analytics | |
CIPLA | ₹113,950.0 Cr | -4.3% | -3.2% | -3.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹99,682.3 Cr | -3% | -12.3% | 13.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,261.6 Cr | -3% | -6.5% | -12.7% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -4.3% |
0.4% |
-10.2% |
SENSEX | -3.4% |
-4.4% |
0.6% |
You may also like the below Video Courses